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ABSTRACT 
5 ~ - Pregnane-3c(, 2oo(-diol Excretion in Urine of 
University Women During the Menstrual Period 
by 
Rita Shin-hui Liao, Master of Science 
Utah State University, 1968 
Major Professor: Dr. Etltelwyn B. Wilcox 
Department: Nutrition and Biochemistry 
Five normal healthy young university women while on self-chosen diets 
and living under normal conditions served as experimental subjects in this 
study. Urinary pregnanediol was measured for 10 days of the menstrual cycle. 
Meal frequency ( 3 meals vs. 2 meals with no breakfast) was also included in the 
study. 
A modification of the method of Eberlein and Bongiovanni on thin layer 
chromatography was used to determine pregnanediol in the urine sample. 
Urine pregnanedfol excretion was in the pattern as investigated by other 
workers. The values rose in the latter half of the menstrual cycle, and fell prior 
to the onset of the next period. 
No relationship was found between pregnanediol level and meal frequency. 
A larger number of subjects are recommended in the further work of this 
problem. 
(74 pages) 
INTRODUCTION 
The high inciden ce of coronary heart disease in humans of middle-age 
and older in the United States prompted research in the many areas which are 
known to or seem to have possibilities in helping to decrease the incidence 
of coronary heart diseas e and athersclerosis. At least nine factors are known 
to be involved in the control and regulation of athersclerosis . One of these, 
serum cholesterol and its metabolism, was one of the first factors to be 
intensively studied. Scientists soon learned that the serum content of cholesterol 
is easily measured and that the serum level could be influenced by changes in the 
diet. In the study of the metabolism of cholesterol, its role as a precursor of 
hormones and other steroids of physiological interest, has prompted a systematic 
investigation of normal and disordered human sterol metabolism in various labo-
ratories. 
The concept that atherosclerosis is a metabolic disorder (Adlersberg, 
1951) involving chiefly lipids and lipoproteins has stimulated extensive investi-
gation of the endocrine influences on circulating lipids and on lipid metabolism. 
Age and sex differences in the distribution of serum lipoproteins have been 
reported by various laboratories. Normal young women have a relatively 
greater cholest:erol concentration in the serum o(_-lipoprotein fraction, and 
correspondingly smaller amounts of cholesterol in the {3-lipoprotein fraction 
than normal men of corresponding ages. This difference is not apparent 
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after the menopause (Adlersberg, 1958). Other evidence has accumulated demon-
strating that myocardial infraction occurs much more frequently in men than in 
women, parti cularly under the age of forty (Katz et al., 1953; Barr, 1955). 
Na tu rally occurring estrogens corrected the abnormal lipid and lipo-
protein pattern of survivors of myocardial infraction (Eilert, 1949). It is not 
unreasonable, then, to suppose that the effects of estrogens on lipid metabolism 
may be of therapeutic value in coronary artery disease. Androgen, on the other 
hand, may have an adverse effect. Because the incidence of estrogenic side 
effects is high, parti cularly in middle-aged man (Russ et al. , 1951; Oliver et al. , 
1956; Robinson et al., 1956 ; Steiner et al., 1956), investigators have employed 
estrogen-androgen combinations to avoid the undesirable estrogenic action, yet 
the studies to date have not been useful (Russ et al., 1955; Oliver et al'l, 1956; 
Adlersberg, 195 7). 
Another female hormone, progesterone, has more recently been the 
object of intensive studies. The urinary titers of this compound may be taken 
as an index of corpus luteum function. The chief catabolic metabolite of the 
progesterone is 5 f -pregnane-3l(, 20 9(--diol. Recently, investigators are 
working in the areas of relationships between the urinary pregnanediol excretion 
and breast cancer (Stern et al., 1964; Kim, 1965; Marmorston et al., 1965; 
Schweppe et al., 1967), endometrial cancer (Kelley et al., 1965), lung cancer 
(Marmorston et al., 1967) , and the sex of fetus (Rawlings et al., 1964). There 
is only limited information on the relationship between the level of progesterone 
and the concentration of serum cholesterol in normal adult people while living 
under normal conditions. 
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This study is a part of a larger problem to determine relationships that 
exist among serum cholesterol, serum fatty acids, and concentrations of estrogens 
and degradation products of progesterone and the androgen and adrenal steroid 
hormones in urine as influenced by dietary factors. Simultaneous studies of these 
factors in human subjects while living in their homes under normal conditions have 
been very limited. Therefore, analysis of these biochemical metabolites and a study 
of their relationships should give basic data on the normal individual while eating 
and living as usual. One phase of the larger study, the urinary pregnanediol 
excretion in normal healthy young university women, at different days of the 
menstrual period, was the objective of the following report. Five university women 
were selected to cooperate in this study. All subjects were maintained on self-
chosen diets for which the calorie, carbohydrate, fat, and protein content was 
calculated. They were on two or three meals a day (with and without breakfast). 
A 24-hour urine sample and blood sample were collected on day 1, 4, 7, 9, 11, 
13, 15, 17, 20, and 26 of the menstrual cycle and at day 1 of the next cycle. 
Urinary pregnanediol waS; estimated by a modification of the method of 
Eberlein and Bongiovanni on thin layer chromatography (Chiang, 1966). 
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REVIEW OF LITERATURE 
History 2 Chemistry, and Isolation 
In 1929, Corner and Allen prepared an extract of corpora lutea with 
nonpolar solvents that eff ectively maintained pregnancy in ovariectomized 
rabbits and that work ed together with estrogen to produce a proliferated uterus 
suitable for implantation of the blastocyst. They found that the proliferative 
effect on the rabbit's uterus could be used as a bioassay for following the 
purification of the active material that led to the isolation of progesterone, 
the hormone of the corpus lateum . Pregnanediol, urinary metabolite of the 
corpus luteum hormone, was discovered by Marrian (1929) in human pregnancy 
urine. Since pregnanediol was quite inactive biologically, no indication of the 
identity of progesterone was forthcoming until it was actually isolated from 
ovarian tissue. Four groups of workers in 1934 obtained progesterone almost 
simultaneously by extraction of sows' ovaries, and its structure was determined 
in the same year. 
Butenandt ( 1930) isolated the same compound as Marrian' s and showed 
the correct formula to be C 21H360 2, and later he provided clear evidence for 
its structural relation to the bile acid and named it "Pregnanediol. " Odell and 
Marrian ( 1936) showed that pregnanediol was present in urine as a water-
soluble acid-hydrolysable conjugate. Also in 1936, Venning and Browne 
reported the isolation of pregnanediol glucosiduronide (as its sodium salt from 
5 
pregnancy urine). This discovery was of considerably importance since it led 
to the development by the discoverers themselves of the first method for the 
quantitative determination of pregnanediol in urine which enabled them to prove 
that pregnanediol is the main end product of progesterone metabolism (Venning, 
1937; Venning and Browne, 1937). This early phase of the pregnanediol story 
was brought to an end in 1944, when the late Head and his co-workers at McGill 
(Heard, Hoffman, and Mack, 1944) proved by an elegant piece of work that in 
pregnanediol glucosiduronide, the glucuronic acid moiety is combined with 
pregnanediol through the C-3 hydrozy group of the latter. 
Biosynthesis of the Hormonal Steroids 
The biosynthesis of the steroid hormones by adrenal, ovary, and testis 
appear to proceed through essentially identical pathways (Figure 1). The adrenal 
cortex may be thought of as the best potential. It can synthesize all of the steroids 
produced by ovary and testis. A common pathway for the formation of the steroid 
hormones can be defined for the adrenal cortex and the gonads. Variations depend 
on the relative specialization indicated for these glands. Beginning with activated 
two carbon fragments of acetyl-coenzyme A, a series of NADPH (TPNH) dependent 
condensation reactions has been demonstrated which ultimately yields the linear 
c30 compound squalene. Through cyclization and elimination of three methyl 
groups, cholesterol is formed. The liver and most other tissue, as well as the 
steroid producing endocrine glands, _ can synthesize cholesterol. Cholesterol is 
the most important, and may indeed be the sole precursor of the steroid hormones. 
Acetate 
? 
HO 
CIH 3 // Cholesterol 
, CH3 
C=O I 
C=O 
I / 
1HO 5 ~ - p~~gneaitlone 
f I 3 
, ~ 
0 Progesterone CH3 t' cLo 
=O 
--OH 
1 
I ~ 
~ 
0 
OH 
'Hef' 
117-oC-oH-Pregnenolone 
: t 1 7-c{ -OH - Progesterone t 0 
1
~11 
,~ 
HIT ~ 
Dehydroepiandrosterone Androsterone 
,,20 
19-0H-Androsterone 
lo 
ti 
HO/w 
Estrone 
0 
? 
~ h 
CH3 I 
C=O 
I 
0 
6 
Testosterone Acetate 
I 
I 
O~~OH 
Testosterone 
OH f 2 
I 
,,,,OH 
CH 
0 
19-0H -Testosterone 
HO 
Estradiol-1 7 
Figure 1. Biosynthesis of the sex steroids. Enzyme systems required: 
(1) 3 ~-01 dehydrogenase. (2) 19-hydroxylase. (Segre and 
Labotsky, 1964, p. 13 7) 
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The adrenal and gonads have specialized abilities to convert this molecule into 
the biologically active hormonal steroids (Lloyd, 1964). 
The DPN-dependent 3 ~ -hydroxysteroid dehydrogenase system of the 
adrenal cortex catalyzes the conversion of pregnenolone to progesterone. The 
same dehydrogenation is accomplished by the corpus luteum and the placenta. 
Since the testis and ovary also effect the conversion of cholesterol to pregnenolone 
and progesterone, the biosynthesis of the C-19 and C-18 steroid hormones from 
cholesterol by these five glands seems to be the initial pathway. 
The concept that cholesterol is a precursor of the adrenal steroid hormones 
was observed early (Long, 1947). He showed that the amount of cholesterol in 
adrenal glands is markedly decreased when the production and release of hormones 
is stimulated. It had also been shown by Bloch ( 1945) that the administration of 
deuterium-labeled cholesterol to a pregnant woman gave rise to labeled pregnanediol 
in the urine, presumably, the administered cholesterol was converted in the placenta 
to progesterone, from which pregnanediol was then formed. Subsequent work 
14 demonstrated that adrenal tissue can convert C -labeled cholesterol to labeled 
progesterone (Bligh et al. , 1955), as well as to corticosterone and cortisol 
(Hechter et al. , 1953). The cholesterol is a more efficient precursor of the 
hormones than is acetate. 
Source and Metabolism of Progesterone 
Progesterone is the most potent natural progestogen and has been isolated 
from the corpora lutea and placenta. It is also an intermediate in the biosynthesis 
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of the adrenocortical steroids and the testicular androgens. The study of Davis 
and co-workers (1952) and Klopper and associates (1957) have shown that after 
injection of ACTH (adrenocorticotropic hormone) in women the excretion of 
pregnanediol incr eased slightly. It was concluded that the adrenal cortex may 
produce prog esterone . Balfour and colleagues (1957) isolated relatively large 
amounts of progesterone from the adrenal vein of the sheep and cow. However, 
there is no reason to assume that the human adrenal cortex produces significant 
amounts of progesterone during pregnancy. 
Small amounts of progesterone are thought to be secreted by the pre-
ovulatory follicle and the titers rise markedly during the course of pregnancy 
(Short and Eton, 1959). Pregnanediol excretion in pregnant women rises pro-
gressively after the second or third month and falls precipitously after loss of 
the placenta (Venning and Browne, 1937). The indications are that the corpus 
luteum of the human ovary produces progesterone during early pregnancy, whereas 
an additional supply is secreted by the placenta after the second month. It was 
indicated by Pearlman (1954) that the progesterone level is at 1-1. 5 mg per kg 
of placenta. The source of the progesterone during pregnancy apparently varies 
with the species (Lloyd, 1964). 
The position of progesterone in the conversion of acetate and cholesterol 
to C 19 steroids has been indicated previously in Figure 1. This provided an 
explanation for the formation of l 7CA._-hydroxyprogesterone, androst-4-ene-3, 
17-dione, and testosteron e on incubation of progesterone with testicular, ovarian, 
adrenal, or placental tissu es. These three products, therefore, can be considered 
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as derived fr om progesterone metabolism. In addition, progesterone may give 
rise to estror e and estradiol, via testosterone (Drill et al. , 1956; Dorfman, 
1957). Form 1tion of these es trogens has been demonstrated experimentally in 
studies in wh'.ch prog e sterone has been incubated in vitro with human ovarian 
tissue (Solomm et al. , 1956). 
Progest ero ne , unlik e the estrogens, is not present in human urine or 
feces. Many experi ments have shown that progesterone disappears very rapidly 
from the bloo1 (Haskins, 1950 ; Butt et al., 1951; Zander, 1954; Zarrow et al., 
1954; Hinsberg et al. , 1956). It has not been clear whether this is due to rapid 
elimination through partition into the tissues or through a true inactivation by 
chemical transformation of the molecule (Lloyd, 1959). 
A number of C-21 metabolites related to progesterone are present in 
the urine, but none of these has any progestational potency, and its excretory 
metabolites seem to vary with the species. The feces of pregnant cows contain 
large amount s of androgen, but very insignificant amounts are found in the 
feces of bulls and nonpregnant animals. It is possible that the placental 
pDogesterone of the p~egnant cow is converted to androgen and excreted 
through the feces. Rabbit liver can convert progesterone to pregnanediol; 
pregnane-3, 20-dione and pregnane-3 ol -Ol-20-one are also formed. On the 
other hand, rat liver appears to be unable to reduce the 20-keto group of 
progesteron e, but this reaction can occur in some other rat tissues, since 
eviscerated rats convert progesterone to 4-pregnen-20 o(-01-3-one (Wiest, 
1956). 
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:n human, mor e significant quantitati vely as a metabolite of progesterone 
is pregnm e -3 «, 20 o(-di ol , a r edu ction product formed from progesterone chiefly 
in the li V3r, where it is coupl ed with glucuronic acid to form the chief urinary 
metaboli ·e of pr ogester one , pr egnan edio l glu cosiduronate. Reduction of the C- 120 
ketone group of pro gest ero ne to th e 20 c(- and ~ -hydroxy isomers also occurs 
hepatical.y. In the kidney (Wiest and Berlin er, 1954 ; 1956 ; Ganis et al., 1956), 
the end p~odu ct ma y b directl y excre ted in the urine . Pr egnanediol formed in 
the liver an ent er the int es t ina l tract via th e bile, or be carried in the circulation 
to the kichey and excre ted in the ur ine , as shown in Figure 2. 
:n addi ti on to he pati c and renal ina ctivation it has been shown by these 
workers ·.hat inact ivat ion of prog e steron e occurs also in peripheral tissues. 
Accordin g to Wies t ( 19 57) , the per iph er al tissu e s have relatively few enzymes 
for the rEduction of the A ring. Th e s e tissues reduce chiefly the side chain. 
~ew info r mation about the excretion of the metabolites of progesterone in 
the bile a1d stoo l cam e from the work of Wiest and co-workers ( 19 55), Davis and 
associate 3 (19 56, 19 57) 9 and Sandberg and Slaunwhite (1958). Sandberg and 
Slaunwhit~ hav e postulat ed an enterohepatic circulation for the metabolites of 
progester one in the human. The metabolites appearing in the bile and stool are 
not comp lete ly identifi ed. 
Although pr egnan ediol is not the sole metabolite of progesterone and is 
not derived entirely from prog e steron e , pregnanediol excretion in the urine is a 
convenie nt s e miquantita tive ind ex of progesterone elaboration and metabolism. 
Pregnane diol det erminations ar e of added significance if correlated with physiological 
11 
Progesterone CH3 I 
CHOH 
De soxy-corticosterone 
in liver 
and kidney 
Pregnanediol 
yOOH 
H-C-OH 
HO-C-H 
I 
ij-y-OH 
H-y-OH 
CH20H 
/ 
Glucuronic acid 
coo HWO/ 
OH 
Pregnane-3Cl-diol glucosiduronate 
t 
Kidney 
excret in urine 
Figure 2. Metabolic precursors of pregnanediol and its metabolism. 
The heavy arrow indicates the major precursor of urinary 
pregnanediol. (Serge and Lobotsky, 1964, p. 144; White, Handler 
and Smith, 1964, p. 865) 
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status. In women with normal menstrual cycles the corpus luteum is the major 
source of progeste r one ; during pregnancy, progesterone rises chiefly in the 
placenta espe cially in the late r period of gestation. 
Two addi t ional compounds with progestational activity and representing 
metabolites of prog e sterone have been isolated from human ripe follicles, corpora 
lutea, and pla ce nta . These substances are preg-4-ene-3-one-20 o(-ol, with ap-
proximately one-third to one-half the progestational activity of progesterone, and 
the corresponding 20 ~-ol isomer, with one-tenth to one-fifth the activity of 
progesterone ( Zander et al. , ··1958). Of interest is the observation that some 
samples of human milk may contain the 20 ~-ol isomer of urinary pregnanediol, 
and that this compound specifically inhibits in vitro the enzymic formation of 
bilirubin digluouronide. There appears to be an interesting correlation between 
the occurrence of this steroid in human milk and the appearance of hyperbilirubinemia 
in some br east-fed infants (White ,et al. , 1964). 
Effect of Progesterone 
It is difficult to describe the physiology of progesterone because it 
normally acts in conjunction with estrogens and other steroids and it produces 
few specific changes when acting alone. In general. it may be said that estrogens 
promote primarily growth processes, whereas progesterone encourages tissue 
differentation . At approximately the mid-point of the traditional 28-day cycle 
ovulation occurs. By this time a corpus luteum is formed which secretes 
progest erone (Corner and Allen, 1929 ; Allen, 1932; Favold and Hisaw, 1932; 
13 
Allen and Wint erst e iner, 1934) , free progesterone becomes demonstratable in 
plasma (Forbes, 1950; Forb e s et al. , 1950; Rock et al., 1957), and pregnanediol 
appears in incr e ase d amounts in the urine (Venning et al. , 1937). Plasma 
progest eron e level s r each a peak on about the twentieth or twenty-fifth day 
coinciding with the peak sto r ag e of glycogen in endometrial epithelium which 
begins on about the four teenth day. Urinary pregnanediol may fluctuate during 
this tim e withou t evident pat te rn, though an increase is expected because of its 
derivation from prog e st eron e (Danowski, 1962). 
Prog est er one acts upon the endometrium, previously prepared by 
estrogen, indu cing mucus se cretory activity indispensable for implantation of the 
ovum. If pregnan cy ensues, continued secretion of progesterone is essential for 
completion of term. Progesterone also contributes to growth of the breasts and 
is thought to maintain the uterus quiescent during pregnancy (Astwood, 1939). 
Progesterone exerts an antiovulatory effect when given during days 5 to 25 of the 
normal menstrual cycle (Fried et al. , 1958); this is the basis for the use of 
certain synthetic progestins (17o( -Ethynyltesterone, 19-Norprogesterone, 
17o( -Ethynyl-19-nortesterone, 170\_ -Ethyl-19-nortesterone, 17o(_-Ethynyl-
17-hydroxy-5(10)-estren-3 one) as oral contraceptive agents. 
Progest erone in very large doses will promote retention of salt and water, 
its action thus resembling that of certain adrenal cortical hormones (Fruton, 
1953; White et al., 1964). 
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Effect of Sex Steroids on Ovulatory Mechanism 
The long-term effects of androgens and estrogens on the gonadotrophin-
releasing mechanism are in general inhibitory. They tend to suppress follicle 
growth to the point where ovulation is eliminated simply by the absence of com-
petent follicles. A chroni c effect of progesterone, on the other hand, is prima-
rily to suppress the preovulatory release of luteinizing hormone. Short term 
effects of estrogen and progesterone are, by constrast, excitatory for the central 
ovulation mechanisms. There are indications that estrogens and progesterone 
can induce the discharge of luteinizing hormone during late diestrus in the rat, 
or it can greatly lower the neural threshold for triggering the hormone release 
in the estrous rabbit, either by reflex stimulation or by electrical stimulation 
for the brain. Injection of estrogen can also induce ovulation, but its full 
effect is less abrupt than that of progesterone, and release of ovulating hormone 
takes place only after a priming period of about twenty-four hours in the adult 
rat or two or three days in the immature rat or adult rabbit. 
The hypophysis of a "masculinized" female rat is that the masculinity 
can be induced by release of the ovulating hormone after administration of 
progesterone followed by electrical stimulation of the tuber cinereum. 
Progesterone, given concomitantly with the follicle-stimulating hormone, 
markedly decreased the follicle stimulating effect of the gonadotrophin, presum-
ably by a direct effect on follicular tissues. 
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Pregnanediol-As a Test for Ovulation 
There are three methods frequently used for determining the occurrence 
of ovulation. They are based on the assumption that the secretion of progesterone 
is by a corpus luteum that has formed following ovulation. Although there may be 
progesterone secretion by luteinizing thecal cells in the absence of ovulation, the 
amount of progesterone formed is small, and physiologically not very important. 
Significant progesterone during the latter part of the menstrual cycle is excellent 
evidence that ovulation has taken place. 
One dependable method for estimation of physiological progesterone effect 
is by study of the endometrial biopsy obtained during the latter part of the luteal 
phase of the cycle. The optimal secretory response in the endometriam is generally 
at about the ninete enth to twenty-third day of the cycle of a woman who regularly 
menstruates in twenty-eight-day cycles. The secretory response is still present 
subsequent to this, but the levels of corpus luteum secretion of progesterone tend 
to decrease so the endometrial response may be somewhat difficult to assess. 
A second means of estimating the physiological effects of progesterone 
is by measurement of its thermogenic effect. Progesterone increases body 
temperature, probably through the action of its degradation products. A rise in 
the basal body temperature after the estrogen peak that is sustained throughout 
the latter part of the menstrual cycle is circumstantial evidence that progesterone 
is present and, therefore, that ovulation has taken place. 
The demonstration of the excretion of increased amounts of urinary 
pregnanediol during the latter phase of the menstrual cycle is excellent evidence 
of progesterone formation by the corpus luteum . \Vb.en the normal woman 
excretes 5 or 6 mg of pregnanediol daily, her own corpus luteum probably 
synthesi zed about 50 mg of progesterone each day (Lloyd, 1964). 
Recent Research on Pregnanediol 
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Rec ently, inv esti gators are working in the areas of relationships between 
the urinary pregnan ediol excretion and the breast cancer, benign breast disease 
(Stern et al., 1964 ; Kim, 1965 ; Marmorston et al., 1965; Schweppe et al., 1967), 
endometrial cancer (Kell~y et al. , 1965), lung cancer (Marmorston et al. , 1965), 
bacteriostatic action on Staphylococci and other organisms (Yotis et al. , 1966), 
neonatal hyperbilirubinemia (Ramos et al., 1966), and/or the sex of the fetus. 
The excretion of pregnanediol in the urine of pregnant women is an index 
of the progesterone in the blood. Review of pregnancy in a large series of 
abortion-prone women confirmed the observation of a high male-to-female ratio 
in babies of patients with high pregnanediol excretion, and a reversed ratio in 
those with low pregnanediol excretion. When the pregnanediol excretion was 
interzone, the number of male and female babies was equal. It would appear 
that the excretion of pregnanediol shows a distinct variation depending on whether 
the placenta is of "male" or "female" type (Rawling et al., 1964). 
Analytical Methods 
The determination of progesterone in blood would be helpful in diagnosis 
of clinical stat es such as corpus luteum insufficiency and threatening abortion. 
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However, the methods are too complex and time-consuming for the assay to be 
useful in a clinical laboratory. 
Urinary assays for progesterone metabolites are useful. Although pre-
gnanediol (5 i~-pregnane-3 c(, 2ooC_ -diol) is not a unique metabolite of progesterone 
(it is derived from desoxycorticosterone as well), it has proved to be a useful 
measure of progesterone production. When progesterone is injected, the mean 
recovery of material as urinary pregnanediol is 13 per cent. In the majority of 
cases, the conversion falls into quite a narrow range of 11 to 14 per cent. It has 
proved useful in studying abnormalities of menstruation and fertility as well as 
in studying abortion early in pregnancy and placental function in late pregnancy. 
The development of methods for determining urinary pregnanediol 
originated with Venning (1937) and involved the gravimetric assay of pregnanediol 
glucosiduronate. In this procedure sodium pregnanediol glucosiduronate was 
extracted with butanol and purified by an acetone precipitation technique. Among 
the disadvantages of this method were the occurrence of emulsions during the 
butanol extraction and the difficulty of purifying the extract (Sinowara, 1940). 
Astwood and Jones (1941) attempted to overcome the difficulties of the Venning 
method by hydrolyzing the conjugate with mineral acid in the presence of toluene. 
This method has gained wide acceptance, although many modifications have been 
reported. deWatteville (1951) and Stimmel et al. (1952) introduced alumina 
column chromatography of the crude urinary extracts to improve the specificity 
of ear lier methods. The advent of gas chromatography of steroids prompted 
many investigators to apply this technique to the determination of pregnanediol 
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in biological extracts. In most cases the toluene-acid hydrolysis procedure has 
been utilized (Seegar Jones et al., 1962; Cox, 1963; Jansen, 1963; Turner et al., 
1963; Woti z , 1963 ; Chamberlain et al., 1964) and the extract submitted to 
analysis either directly or following prepurification and acetylation. Enzyme 
hydrolysis has be en reported by some investigators. The extract is purified by 
means of thin layer or column chromatography (Klopper, Michie and Brown, 
1955) and acetylated, converted to the trimethylsilyl ether, or analyzed directly 
(Patti et al., 1963 ; Kirschner et al., 1964; Marmorstan et al., 1965; Raman 
et al. , 1965). 
The methods employed usually comprise the following steps: (1) hydrolysis 
of the pregnanediol glucuronide, the form in which most of the pregnanediol is 
excreted in the urine, (2) extraction of the free pregnanediol, (3) separation of the 
pregnanediol from other compounds simultaneously extracted, and (4) some sort 
of quantitative or semiquantitatively estimation of the separated pregnanediol. 
Since elution of pregnanediol from the column without being contaminated 
by other compounds, especially the other chemical related corpus luteum hormone 
metabolites, is very difficult, it was found to be more advantageous to carry out 
the separation by thin-layer chromatography (TLC). By this method it is possible 
to localize the pregnanediol spot precisely and separate it from any other com-
pound. Waldi et al. ( 1962) developed a method using this principle, which gave 
a semiquantitative estimation of the amount of pregnanediol in urine. They pro-
posed use of the method as a pregnancy test. 
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A method which uses paper chromatography described by Eberlein and 
Bogiovanni (1958) is probably the most specific and most sensitive method for 
estimation of pregnanediol in a small volume of urine. A modification of the 
method of Eberlein and Bongiovanni in which paper chromatography was changed 
to thin-layer chromatography was successfully used by Chiang (1966) in this lab, 
and was used in this study. 
Urinary Pregnanediol Level 
Since the development of analytical methods for pregnanediol, various 
studies have been done on urinary pregnanediol excretion in normal and abnormal 
human-beings. 
In Table 1, differences in pregnanediol excretion between normal men 
and women are shown. Pregnanediol excretion is low in the follicular phase, 
increases in the luteal phase and pregnancy, and drops after the parturation and 
in post-menopausal women. 
Information has been sought from the studies of the excretion of the new-
born and amniotic fluid. Pregnanediol has thus far not been detected in urine of 
the newborn, at least by the usual methods having a sensitivity of as little as 1 mg. 
Philipp (1936) and Hoffman and Unde (1954), using biological tests, found up to 
4 mg of progesterone in the urine of newborn babies in the first 24 hours after 
delivery. It has been isolated also from the amniotic fluid (an average value of 
0. 14 mcg per ml). On the basis of these findings, it was thought that the 
progesterone is not metabolized in the fetus and that some of the progesterone 
Table 1. Urinary pregnanediol values reported in the literature 
No. of Value (mean) 
Sex subjects mg/24 hours Condition Investigator Method 
M - 0. 1-0.8 mg/1000 ml urine. Normal Astwood et al. , Gravimetric 
1941 method 
F - 1 Preovulatory phase Grollman, 1941 
6 Late post ovulatory phase 
M 9 0.38-1.42 (0.92) Normal Klopper et al. , Column 
1955 chromatography 
F 4 0.78-1.50 (1.12) Proliferative phase 
2 2 . 4-4. 2 ( 3. 3) Luteal phase 
5 o. 28-0. 86 (0. 63) Post menopause 
M 1 0.45-0.56 Normal Eberlein et al. , Paper 
F 9 0.29-3.70 1958 chromatography 
M - 0-1. 5 Normal Eugene et al. , Column 
F - 0.1-2.0 Proliferative phase 1964 chromatography 
2.0-7.0 Lu teal phase 
M 4 0. 90-1. 18 Normal Ehrlich, 1965 Thin layer 
F 6 11. 73-41. 52 Pregnant chromatography 
M - 0.2 Normal Hawk, 1965 Paper 
F - 0.2 Follicular phase chromatography 
5-10 Luteal phase and from 
fertilization to the end of the N) 0 
ovarian phase of pregnancy 
Table 1. Continued 
No. of Value (mean) 
Sex subjects mg/24 hours 
F - 1 
6 
M 2 0.13-0.29 
F 1 0.60 
F 1 7.0 
F 1 31. 0 
M 4 o. 15-2. 46 (0. 77) 
F 5 0. 14-1. 85 (0. 87) 
0. 20-5. 76 ( 1. 77) 
Condition 
Preovula tory phase 
Late post ovulatory 
mg/1000 ml urine 
Normal 
Follicular phase 
1st trimester pregnancy 
3rd trimester pregnancy 
Normal 
Proliferative phase 
Lu teal phase 
Investigator 
Bang, 1964 
Raman et al. , 
1965 
Chiang, 1966 
Method 
Thin layer 
chromatography 
Gas 
chromatography 
Thin layer 
chromatography 
tv 
1--' 
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is excreted unchanged, it may be that some is returned to the mother (Lloyd, 
1959). 
Raman et al. ( 1965) could not detect any pregnanediol excretion in urine 
of babies (male and female, from 3 days to 3 years old) with congenital adrenal 
hyperplasia, obese and hirsute, and after adrenal suppressions. 
No data can be found for the difference between young boys and girls 
prior to puberty, and no study has been conducted in the field or pregnanediol 
excretion an old-aged men. 
From a clinical point of view, although there may be variation in the 
estimations of total pregnanediol output according to the method used, the 
significance of the value will be assessed from the range of normality found 
using that particular method. 
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METHOD OF PROCEDURE 
Experimental Design 
Five normal healthy young university women were selected to cooperate 
· in this study . All subjects were given a physical examination by the University 
Health Service 1 before starting the experiment and were found to be in excellent 
condition . Blood pressure and hemoglobin were normal, urine analysis for 
sugar and albumin were negative. 
All subjects were allowed to continue on their self-chosen diets but were 
asked to maintain constant weight and to go without breakfast for one of the two 
test periods . Dietary records were kept of all foods eaten each day before urine 
was collected. The content of calories, protein, fat, carbohydrate, saturated 
fatty acids, unsaturated fatty acids (oleic and linoleic), and cholesterol was then 
calculated from the food tables in the U. s. D. A. Agricultural Handbook No. 8 
by Watts and Merrill (1963), and additional cholesterol values from a table by 
Okey ( 1945). 
Two menstrual cycles period of 28-34 days were studied, one was in the 
fall from November 5, to December 19, and the other was in the winter between 
January 2, and February 12. In order to minimize the effect of environmental 
factors such as class work, examination, emotion, weather, etc. , three of the 
1 Doctor S. M. Budge 
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subjects received their regular three meals a day, while two went without 
breakfast for the first test period, and the eating pattern was reversed for the 
two groups of subjects in the second period as shown in the experimental design 
in Table 2. 
The subj ec ts were weighed before breakfast each morning that blood 
was obtained, and then served breakfast (if allowed) in the Food and Nutrition 
Research Laboratory. Age, height, and body weight of subjects are presented 
in Table 3. 
One of these five subjects, J. B. , was married. As she became pregnant 
in the second test period her values obtained in the second period were not included 
in the average but are presented separately. 
Collection and Storage of Urine Sample 
Collection 
A 24-hour urine sample and blood sample from the finger-tip (for lipid 
determination) were collected on day 1, 4, 7, 9, 11, 13, 15, : 17, 20, 26, of the 
menstrual cycle and at day 1 of the next cycle. Two menstrual cycles were 
studied for each subject. One hundred and eight urine samples were analyzed. 
Instructions for collecting 24-hour urine specimens were given to each 
subject, that is, to discard the first morning specimen on the day of collection 
and to collect all urine voided up to and including the first morning specimen of 
the next day. Containers of adequate size (two one-quart mason jars) labeled 
with name and date were used for 24-hour urine collection of each subject. 
Table 2. Experimental design 
Subjects 
Periods 
1st: Nov. 5- Dec. 19 
2nd: Jan. 2- Feb. 12 
Two meals 
with no breakfast 
D. W. 
P. B. 
J. B. 
A. M. 
C. L. 
Table 3. Age, weight, and height of subjects 
Subjects 
J.B. C. L. P. B. 
Age 21 21 22 
Weight (pounds) 116. 5 145.5 131 
Height (feet) 5 '4. 5" 5 '9" 5 '6. 7" 
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Three meals 
with breakfast 
J. B. 
A. M. 
c. L. 
D. w. 
P. B. 
D. W. A. M. 
23 26 
168 115. 5 
5'8. 5" 5 '4" 
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Creatinine values were determined on the fresh urine to check the 
accuracy of the completeness of the total urine for the 24-hour collection. 
These values have been shown to be nearly constant for a given individual. 
Folin's method (Hawk et al., 1954) was used in this analysis. Results were 
all within the range of creatinine values for normal subjects. 
Storage 
A mi xture of penicillin and streptomycin solution (1000 units of 
penicillin and 5 mg of streptomycin for each 24-hour collection) was used as a 
preservativ e to prevent both bacterial contamination and deterioration upon 
frozen storage . The volume of urine was recorded, the urine mixed well, 
and 4 small bottles (about 120 ml of urine per bottle) of the urine were then 
stored at -10 ° C until the analyses for various steroid hormone end products 
could be made. 
Analysis of Urinary 5 ~ -Pregnane-3 al 20d,;-diol 
Method 
The method used in this study was a modification of the method of 
Eberlein and Bongiovanni (1958) as described by Chiang (1966), which uses thin 
layer chromatography for purification of the sample (see Appendix). 
Duplicate aliquots were analyzed for each sample. Those samples that 
did not peak at 425 my, and/or those showing a large difference in the results 
from duplicates were repeated again. 
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Recovery 
The precision of the method was established by a recovery test. The 
recovery test was run in duplicate, and it was made on each subject's urine. 
To a 10 ml of urine sample was added 5 mcg of standard 5 fJ-pregnane-3c(, 
20c(-diol, which was run at the same time with the 10 ml urine sample by 
following th e routine procedure. The results were shown in Table 4. 
Table 4. Recovery test of urinary pregnanediol 
Pregnanediol mcg 
Subjects 10 ml urine Std. a + 10 ml urine 
Recovery 
% 
A. M. 12.11 16.88 96.36 
C. L. 14.29 19.08 96.77 
D. W. 36.87 41. 46 92.73 
J.B. 25.13 29.91 96.56 
P. B. 14.44 19. 14 94.95 
Mean 95.47 
a4. 95 mcg standard 5~ -pregnane-3 c:(, 20 c{-diol 
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RESULTS AND DISCUSSION 
Urinary Pregnanediol Level 
Values of urinary 5 f> -pregnane-3 c(, 20 c(-diol excretion for the five 
subjects, with and without breakfast, during the two experimental periods, are 
pres ented in Table 5 by day of menstrual cycle and the mean concentrations for 
each individual in Table 6. 
The daily excretion of pregnanediol in urine found in this study ranged 
from 0. 24 mg to 1. 69 mg for the first half of the menstrual cycle, and 0. 48 mg 
to 3. 10 mg for the latter half of the cycle. 
The data showed that individual difference existed in the pregnanediol 
excretion. In Table 5, the data showed that the pregnanediol daily output of 
subject C. L. was higher than for subjects A. M. , and D. W. This difference 
also was shown clearly in the mean value for each subject (Table 6). However, 
the values of pregnanediol excretion by subject C. L. was still within the 
normal range as reported by other research workers. 
Effect of menstrual cycle 
The variation among individual data of the excretion of pregnanediol in 
the urine of the subjects by days of menstrual cycle is presented in Table 6 and 
Figure 3. The excretion of pregnanediol rose in the expected fashion during the 
second half of the menstrual cycle, and precipitously fell prior to the onset of the 
next cycle. 
Table 5. Urinary 5 ~ -pregnane-3 c.,;-~' 20 c-:~ -diol excretion values for the individual subje c ts consuming two meals and 
three meals per day by day of menstrual cycle 
Cycle Days of menstrual cycle 
Subject Meals (days ) 1 4 7 9 11 13 15 17 20 26 27-31 Mean 
mg/24 hour urine 
A. M. 2 32 0.78 0.67 1. 13 0.73 0.61 0.89 0. 89 0.89 0.94 2.06 - 0.96 
3 31 0.81 - 0.35 0.76 0.59 0.63 0.84 0.96 1. 27 1. 99 0.42 0.96 
C. L. 2 34 0.77 0.94 1. 15 1.40 0.96 1. 65 2. 19 1.41 2.34 2.16 - 1. 49 
3 29 0.30 o. 48 1. 58 1. 41 1. 10 1. 66 2.63 3.10 2.41 0.69 - 1. 46 
D. W. 2 37 o. 71 0.56 1. 14 0.45 0.67 0. 97 0.73 - 0.55 1. 72 - 0.83 
3 32 0.76 0.37 0.57 0. 71 1. 69 0.76 0.48 - 1. 33 1. 02 - 0.86 
P. B. 2 26 0.77 0.92 0.48 0.95 0 . 79 1. 09 1. 12 1. 84 2.23 1. 68 - 1. 19 
3 31 0.44 - 0.80 1. 33 1. 12 1.18 1. 87 2.84 3.05 - 1. 13 1. 50 
J.B. 2a 
3 32 0.83 0.56 0.74 0.81 0.61 0.24 0.54 0 . 64 2.48 0.97 - 0.84 
Mean 0.69 0.62 o. 89 0.94 0.89 1. 02 1. 25 1. 29 1. 81 1. 74 1. 53 
aSubject J. B. was found pregnant on Feb. 9 in the 2nd test period. The following values are for period 2. 
Days of menstrual cycle 13 15 17 28 31 39 48 66 
--
Pregnanediol mg/24 hour 0.30 0.34 0.42 1.42 1. 62 4.06 5.14 4.67 
N) 
<O 
Table 6. Urinary pregnanediol excretion values for the individual subjects by day of menstrual cycle 
Days of 2reovulatory 2hase 
Subject 1 4 7 9 11 13 Mean 
-
A. M. 0.79 0.67 0. 74 0.74 0.60 0.76 
C. L. 0.53 o. 71 1. 37 1.40 1. 03 1. 66 
D. W. 0.74 o. 47 o. 86 0.58 1. 18 0.86 
P. B. 0.61 0.92 0.64 1.14 0.95 1.13 
J.B. 
a 0.83 0.56 0.74 0.81 0.61 0.24 
Mean 0.69 0.62 0.89 0.94 0. 89 1. 02 0.84 
Da;ys of luteal phase 
Subject 15 17 20 26 27-31 Mean 
-
A. M. 0.86 0.92 1.11 2 . 02 0.42 
C. L. 2.41 2.26 2.38 1.42 
D. W. 0.50 - 0.94 1. 37 
P. B. 1. 49 2.35 2.64 1. 68 1. 13 
J.B. a 0.54 0.64 2.48 o. 97 
c:..., 
Mean 1. 25 1. 29 1. 81 1. 74 1. 53 0 
aValue of only one experimental period 
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Figure 3. The effect of day of menstrual cycle on mean excretion values of pregnanediol of five subjects. c.., ~ 
Although the mean pregnanediol values appeared to be similar from 
da 7s 7 to 11, they showed a slight tendency to rise on day 13 (Figure 4). 
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Fu rther increases were noted through days 15 and 1 7, which reached its peak 
by day 20. The peak between day 1 7 and 20 may have been missed because 
am.lysis was not done every day. The concentration of pregnanediol decreased 
pr ior to the onset of the next menstrual period . Pregnanediol excretion in the 
ur ine for the subjects with normal cycle of 28 da ys reached its peak during days 
17 and 20. The peak would appear on a later day between day 20 to 26 with the 
cycles longer than 28 days ( 30 to 35 days). However , differences in mean 
prEgnanediol excretion between day 20 and 26 were not significant. 
Smaller amounts of pregnanediol were detectable during the first half 
of the cycle. Possibly this pregnanediol was derived from the metabolism of 
adr enal progesterone and desoxycorticosterone. 
The overall means of urinary pregnanediol output per day were found to 
be ) . 84 mg from day 1 to 14 (preovulatory phase), and 1. 53 mg from day 15 to 
28 duteal phase), of the menstrual cycle. Thus, the pregnanediol excretion 
val ues and range of preovulatory phase and luteal phase of this study showed 
close agreement with values reported previously by other investigators in the 
lite r ature (Table 1). 
Because of the variation between subjects, it would be highly desirable 
to cbtain similar basic data on a larger number of subjects to observe the signi-
ficant of the effect of the menstrual cycle on this metabolite. 
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Effect of two meals vs . three meals per day 
Urinary pregnanediol excretion values for the individual subjects with 
and without breakfast by day of menstrual cycle are given in Table 5, and 
Figures 5 to 8, for four subjects. The mean excretion values by meals for the 
five subjects are pre sented in Table 7 and Figure 9. 
There existed no apparent difference of mean pregnanediol excretion 
when the subje cts wer e with or without breakfast (0. 80:0. 88) at the preovulatory 
phase, yet the values were slightly higher with breakfast ( 1. 64 vs. 1. 42) at the 
lu teal phase. 
No difference was found in the pregnanediol excretion values of specific 
days of the menstrual cycle and the mean values of subjects of A. M. , C. L. , 
and D. W. either with or without breakfast. Subject P. B. showed a definite 
increase of pregnanediol output from day 7 through to the end of the cycle during 
the period with breakfast. 
It appeared that meal frequency did not influence the pregnanediol output 
of most subjects. More subjects and greater differences in meal frequencies are 
needed to draw conclusions on this phase of the problem. 
In this study, pregnanediol excretion values were influenced by the 
menstrual cycle to a greater extent than by the frequency of meals per day. 
Values Obtained for Subject J. B. 
Subject J. B. was married. She became pregnant during the second 
experimental period. The last urine sample for analyses was collected on day 
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Table 7. 
Meals 
2 
3 
Mean 
Mean values of pregnanediol in urine of subjects consuming two meals and three meals per day by day of 
menstrual cycle 
Days of menstrual cycle 
1 4 7 9 11 13 15 17 20 26 
Mean Mean 
0.76 0.76 0.97 0.88 0.75 1. 15 0.88 1. 23 1. 08 1. 52 1. 82 1. 42 
0.63 0.47 0.81 1. 00 1. 02 0.89 0.80 1. 27 1. 51 2.10 1. 65 1. 64 
0.69 0.62 0.89 0.94 0. 89 1. 02 0.84 1. 25 1. 29 1. 81 1. 74 1. 53 
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Figure 9. The effect of number of meals on mean excretion values of urinary pregnanediol for 
five subjects. ~ 
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66 after day 1 of the last menstruation. Assuming that she became pregnant 
at time of ovu latio n the data on day 66 represented approximately one and one-
half mon ths pregnant . 
Duri ng the first menstrual period, the pregnanediol excretion pattern 
was found to be in agr ee ment with other investigators. During the second period 
of stud y, the influ ence of the pregnancy was great; the higher pregnanediol 
ex cretion valu es for her was 5. 14 mg for day 48. The data of this study period 
was not inc luded in the calculation with the other four subjects. 
Relationships Among Serum Cholesterol and 
Urinary Pregnanediol, Total Estrogen, and 
Neutral 17-Ketosteroids 
Serum cholesterol, neutral 17-ketosteroids, and total estrogen were 
determined in this laboratory by Sang (1967), Yam (1966), and Lee (1967) on 
the same subjects. The pattern of these three components and of pregnanediol 
are shown in Table 8 and Figure 10. Serum cholesterol was low on day 1 and 
then rose to high level during the first half of the menstrual cycle, and dropped 
to lower leve ls for the second half of the cycle. In contrast, pregnanediol was 
low in the first half of the cycle, and rose for the latter half of the cycle, 
especially, on days 20 and 26. Neutral 17-ketosteroids reached its peak on 
day 15, and total estrogen climbed twice, on the ovulation and on the luteal 
phase of th e cy cle . It appeared that, the concentration of serum cholesterol 
had a recipro cal r el ationship to pregnanediol, neutral 17-ketosteroids, and total 
Table 8. The relationship among serum cholesterol and urinary pregnanediol, neutra l 17-ketosteroids, and total 
estrogen by day of menstrual cycle 
1 4 7 9 11 13 15 17 20 26 
Chol e sterol mg/100 ml 165 191 189 189 191 188 186 188 181 181 
Pregnanediol mg/24 hour 0.69 0.62 0.89 0.94 0.89 1. 02 1. 25 L .29 1. 81 1. 74 
Neutral 17-
ketosteroids mg/24 hour 4.45 5.16 5.51 5.88 5.61 5.95 7.24 5.42 4.69 4.02 
Total 
estrogen mcg/24 hour 13. 43 15. 27 14. 55 25. 48 27. 13 28. 13 30. 13 29. 87 20. 16 20 . 24 
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estrogen. This result would be in agreement with the knowledge that cholesterol 
served as the precursor of sex hormones and adrenal cortical steroids. 
Dietary Intake 
Diet records were kept for all subjects on each day before urine was 
collected. The total dietary content of calories, protein, carbohydrate, fat, 
saturated fatty acid , unsaturated fatt y acid -s( oleic and linoleic acids), and 
cholesterol as calculated is presented in Table 9. 
The mean caloric intake of the four subjects was 1885 calories per day; 
1986 and 1781 calories for 3 and for 2 meals-per-day, respectively. Thus, the 
caloric intake was 205 calories or 10 per cent less on 2 meals a day than on 3 
meals. This difference was due to the higher percentages of calories from 
protein (15. 2 vs. 14. 7 per cent) and fat (38. 4 vs. 37 per cent) and a slight 
increase from carbohydrate ( 46 vs. 48 per cent) on 3 meals vs. 2 meals per 
day . 
All the subjects had a lower caloric intake than the 2100 recommended 
by National Research Council ( 1964), except for one subject who was consuming 
2348 calories on 3 meals. However, this difference in the caloric intake is not 
great enough to effect the study. 
The diets appear to be well balanced. Nutritionists recommend for a 
well balanced diet that the total calories eaten as protein should be 10 to 15 
per cent ; as carbohydrates , 48 to 53 per cent; and the rest as fat. When indi-
vidual dietary intakes were considered, all subjects were consuming diets 
that were within the upper range for protein ( 13 to 1 7 per cent of total calories 
Table 9. Mean daily intake of certain nutrients of subjects on self-selected diets 
Total Unsaturated 
Name of Total Total saturated fatty acids Di etary 
subj ects calories Carbohydrate Protein fat fatty acid Olei c Lino le ic cholesterol 
Gm. Gm. Gm. Gm. Gm. Gm. Mg. 
Two meals per day 
A. M. 1711 192 65 76 28 28 U.3 289 
D. W. 1862 259 62 64 21 26 12.6 294 
C. L. 1730 207 65 71 29 32 11. 4 434 
P. B. 1821 205 70 83 32 28 11. 5 398 
Mean 1781 216 65 74 27 29 11. 7 354 
Percentage of 
total calories ---- 48.5 14.7 37 13.6 14.6 5.9 
Three meals per day 
A. M. 2348 253 85 109 36 52 22.4 328 
D. W. 1745 218 74 64 30 37 5.3 411 
C. L. 2013 244 71 84 34 34 10.9 439 
P. B. 1847 205 73 82 36 32 7.2 383 
Mean 1986 230 76 85 34 34 11. 5 390 
Percentage of 
total calories ---- 46.3 15 38.4 15.4 15.4 5.7 ~ 
c.n 
Table 9. Continued 
Name of Total Total 
subj ects calories Carbohydrate Protein fat 
2 meals 1686 174 71 79 
3 mea ls 1829 199 79 85 
Mean 1757 187 75 82 
Percentage of 
total calories ---- 42 17 41 
Total 
saturated 
fatty acid 
--
Subject J. B. 
33 
34 
33.5 
17. 1 
Unsaturated 
fatty acids 
Olei c Linoleic 
30 8.0 
34 8.7 
32 8.4 
16.3 4.3 
Dieta ry 
cholest erol 
337 
389 
363 
~ 
m 
47 
as protein); adequate in carbohydrate for two subjects ( 48 to 56 per cent), some-
what low carbohydrate intake for two subjects ( 43 and 44 per cent); and medium 
to high fat intake (31 to 42 per cent). The linoleic content of the diet was 5. 9 
and 5. 7 per cent of the total calories on 2 and 3 meals, respectively. The ratio 
of polyunsatura te d fatty acids to saturated fatty acids was 0. 45. The dietary 
chol es terol intake ranged from 289 to 434 mg and 238 to 439 mg daily, on 2 and 3 
meals per day, respectively. 
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CONCLUSION AND COMMENTS 
Basic information of pregnanediol excretion was obtained on specific 
days during the menstrual cycle of normal young healthy women living and 
eating under normal condition. 
As was expected, the data showed that the pregnanediol excretion in 
the urine was greatly affected by ovulation and the luteal phase during the 
menstrual cycle. The excretion value would reach its peak during the days of 
17-20 for the subjects with a normal period of 28 days; with a longer cycle 
the peak would appear later than the twentieth day. The variation between the 
individual subjects was quite great in this study. Since the number of subjects 
in this study was only five , one subject with high or low values would influence 
greatly the pregnanediol mean value. 
There existed a reciprocal relationship between the urinary pregnanediol 
and serum cholesterol. 
No definite relationship was established between the urinary pregnanediol 
and the frequency of meals (with or without breakfast). 
One subject ( J . B. ) became pregnant in the second test period. Her 
data were not included with the other four subjects. Her highest value was 5. 14 
mg on day 48 compared to 3. 1 mg on day 17 for another subject with the next 
highest value. The high values were also sustained for a longer period of time 
(days 39 1 48, and 66). 
Because of the wide variations between subjects, it is recommended 
that the study be repeated using a larger number of subjects, as well as 
analyze for more days from day 15 to the end of the cycle. Relationships 
between biochemical indices would thus be more valid. Also, it would be 
de sirable if the subjects selected for the study had a similar length of the 
menstrual cycle (normal 28 days is desirable). 
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SUMMARY 
Five healt hy university women, while living at home and on self-
chosen diets, were selected to cooperate in the study of obtaining the basic 
data of 5 ~ -pregnane-3c{, 20c:(-diol excretion in urine during the menstrual 
cycle. Effect of meal frequency (3 meals vs. 2 meals with no breakfast) was 
also included in this study. 
Two complete menstrual cycles were included in the test periods for 
each subject. A 24-hour urine sample and blood sample were collected on 
day 1, 4, 7, 9, 11, 13, 15, 17, 20, 26 and at day 1 of the next cycle. Urinary 
pregnanediol was determined by a modification of the method of Eberlein and 
Bongiovanni on thin layer chromatography. 
A diet record was kept for each subject on the day prior to urine 
collec tion . The me an caloric intake was 1885 calories per day, the percentages 
of calori es consumed as protein was 12 to 17, carbohydrate, 48; and fat, 31 to 
42. 
The overall mea ns for urinary pregnanediol output were found to be 
0. 84 mg for the first half of the menstrual cycle, and 1. 53 mg for the latter 
half of the cycle. The range of pregnanediol excretion values was 0. 24 mg to 
1. 69 mg during the preovulatory phase, and 0. 48 mg to 3. 10 mg for the luteal 
phase. Ex cret ion values showed quite wide variations between individual subjects 
in this study. 
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The pregnanediol excretion was greatly influenced by the menstrual 
cycle. It rose in the second half of the menstrual cycle and fell precipitously 
prior to the ons et of the next period, as reported by other investigators. There 
was no definit e evidence that the pregnanediol excretion was influenced by the 
meal frequencies. 
A reciprocal relationship in this study was observed between the 
pregnanediol excretion values and the serum cholesterol. 
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APPENDIX 
Analysis of Urinary 5 @-Pregnane-3 ,!, 20 "' -diol 
A modification of the method of Eberlein and Bongiovanni ( 1958) as 
used by Chiang ( 1966). 
Equipment 
1. Mounting board for glass plates, 22 x 113 cm with retaining 
ledges 1. 8 cm wide along a short and a long side. 1 
60 
2 . De saga standard applicator, Model S-11, for mechanically pro-
ducing a standard thickness. 1 
1 3. Glass plates of uniform thickness: 5 x 20 cm and 20 x 20 cm. 
4. Labeling template, graduated. 1 
5. Developing tank. 2 
6. Racks for glass plates: metal and wooden. 
0 
7. Oven, 110 C. 
8. Hamilton microliter syringes, 10, 20, and 50 lambda . 
9. Hot plate. 
10. Filter paper, Whatman No. 1, 45 x 60 cm sheets. 
11. Pouring funnels, 2. 5 inches in diameter. 
12. Erlenmeyer flasks, 50 ml. 
1 . Brmkmann Instruments, Inc., 115 Cutter Mill Road, Great Neck, 
Long Island, New York. 
2 
Arthur H. Thomas Co., Philadelphia, Pennsylvania. 
Reagents 
13. Sintered glass filters, 15 ml capacity. 
0 14. Water bath, 37 C. 
15. Test tubes, 1. 5 x 15 cm. 
16. Razor blades, single edge. 
17. Conical centrifuge tubes, 50 ml, and 15 ml. 
18. Glass rods. 
19. Serum lifter. 3 
20. Be ckmann spectrophotometer, and 3 ml silica cuvettes. 
1. Silica Gel G obtained from Brinkman. 
2 . Iodine. 
3. Acetone, reagent grade, distilled. 
4. Chloroform, reagent grade, distilled. 
5. Benzene, reagent grade, distilled. 
6. Developing solvent, chloroform: acetone:absolute alcohol= 
85:15:10, v/v/v. 
7. Nitrogen gas. 
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8. 5 ~ -pregnane-3 o( , 20 cl -diol, 0. 1 per cent standard in distilled 
chloroform. 
9. lM, pH 4. 5 acetate buffer. 
3 Obtained from University of Utah Machine Shop. 
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. 4 10. Beta - glucuronidase, 5000 umt per ml. 
11. lN NaOH . 
12. Sulfuric acid mixture: 30 gm sodium bisulfite is cautiously added 
to 200 ml of concentrated sulfuric acid in a 1000 ml beaker (fumes), 
wit h stirring under the hood, and allowed to cool. The acid is 
dec anted into a small bottle in which it may be stored at room 
te mper ature . 
Proc edure 
Hydr oly sis. Duplicate 20 ml samples of urine were used. To 20 ml of 
ur ine in a 50 ml ce ntrifuge tube was added 2 ml of lM, pH 4. 5 acetate buffer, 
and 5000 unit s ( 1 ml) beta -g lucuronidase. Each tube was stoppered with glass 
s toppers to preve nt any loss of the sample during hydrol ysis. Hydr olys i s was 
performed by in cubating the tubes in a 37° C water bath overnight (12 to 18 
hours). Two standard samples, 10 microliters of pregnanediol plus 20 ml water, 
buffer, and ket odase, were also incubated under standard condition. 
Extra ction. After hydrolysis, the samples were extracted with 10 ml 
benzene by the beating technique, which used a footed stirring rod for the beat-
ing. The two layers separated readily on standing, however, if emulsion formed, 
a short centrifugation separated the layers. The benzene layer was transferred 
by means of a serum lifter to a conical 50 ml centrifuge tube. The extraction was 
repeated with another 10 ml of benzene and the extracts were combined. 
4 Sigma Chemical Company, 3500 Dekalb Street, St. Louis, Missouri. 
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Washing and drying. The combined extracts were washed with 8 ml of 
lN NaOH three times, and then 8 ml of water three times, the water lay er was 
re moved, and then dried over anhydrous sodium sulfate. The benz ene extracts 
w re transferr ed to a conical 15 ml centrifuge tube and evaporated to dryn ess 
at 45-50° C under a gentl e stream of filtered nitrogen gas. 
Preparing the glass plates. The glass plates were coated with sili ca 
gel G as follows: 
1. Preparation of glass plates. The glass plates were thorough ly cl eane d 
with a cleaning agent, rinsed well with tap water, distilled water, and air dried 
on a drying rack at room temperature. Just before use, the plates were further 
cleaned by washing with acetone to remove any dust or contaminating materia ls. 
2 . Preparation of the suspension of silica gel G and filling the spre ader. 
Sili c a gel G was used as the absorbent for coating the glass plates. The volume 
of slurry required to coat five 20 x 20 cm plates contained 27 gm silica gel G 
and 75 ml redistilled water in a 250 ml stoppered flask. The flask was shaken 
vigorously for 30 to 45 seconds, and immediately transferred to the open spread er . 
The spreader was held with both hands and drawn across the plates without apply-
ing much pressur e . It is important to finish this step within 4 minutes. 
3. Drying the plates. The plates were left in a flat position for 10 
minutes, and then dried in air overnight. This gave layers that adhered 
particularly well. 
4. Activation. The plates were placed in a drying cabinet. Time and 
temperatur of heati ng were d termined by the r equired activity of the lay er . 
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Heating to 110 C for 2 hours gave the correct adsorption activity. Layers with 
gr ea ter adsorption activity can be obtained by heating for longer times at high er 
te mperatures. 
5. Storage. Since active plates became deactivat ed in moist air, th y 
were sto re d over a desiccant in a desiccator, or in a plate cabinet. If hot plates 
were place d in the desiccator the stopcock must be left open, which has bee n 
provided with a short drying tube filled with silica gel. The layers were thus 
protected as well as possible against laboratory fumes and mechani cal dam age . 
Chromatography. Just before applying the sample, im puriti es wer . 
removed from the plates by placing them in a glass tank, which had been satura te d 
with chloroform. 
The dried sample of pregnanediol was dissolved in 50 microliters of 
chloroform and was applied to the plate with a 20 microliter syringe at a point 
approximately two centimeters from the edge of the plate at right angles to the 
dir ectio n in which the plates were coated. A standard solution of 5 ~ -pregnan e -
3 {, 20 , -dial prepared for thin layer chromatography was applied to the plate as 
a mark for identification. Immediately after the sample was applied, the plate 
was placed in a developing tank which previously had been saturated by adding 
150 ml of dev eloping solvent. The developing solvent was chloroform:acetone: 
absolute alcohol = 85:15:10. Saturation was accomplished by lining the tank with 
a filter pap er wick. When the solvent front had reached a predetermined mark 
( 15 cm), the plate was removed from the 'Chamber, air dried, and quickly placed 
in an iodine atmosphere until the pregnanediol components become visible as 
yellow spots. 
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The plate was removed from the iodine atmosphere, the area of pregnan edio l 
was located, and the portion of silica gel G containing the pregnanediol component 
was immediately scraped off into an Erlenmeyer flask (50 ml) containing th e 
eluting solvent ( chloroform, 20 ml). The silica gel G-pregnanediol mi xtu re wa s 
fil tered through a sintered glass filter into a 1. 5 x 15 cm tube . The flas k wa s 
ri nsed sev er al times , with sol vent to insure quantitative transfer of the pre gnanediol. 
The sol ve nt was evaporat ed just to dryness in a nitrogen atmosph ere while the tu e 
was he ld in a war m water bath. Although thin layer chromatographi c analy sis of 
the componen ts (pregnanediol and steroids) extracted from urine sampl e s sh owed 
good retention, it also showed tailing of the neighboring steroid classes. In order 
to furth er pur ify the pregnanediol it was re - chromatographed by the thin la yer 
pr ocedure and is olated a second time as described above. 
Spectrophotometry. To the dried sample, was added 2. 6 ml of 15 per 
cent sodium bisulfate in sulfuric acid solution. In this mixture the absorban ce of 
pregnanediol at 425 my is more than twice that in sulfuric acid alone. An a cid 
blank was prepared simultaneously. (A silica gel blank is not necessary . ) Th e 
spots of the standard solution of pregnanediol were treated in the same way as 
the urinary extracts. The tubes were rolled to distribute the acid evenly and th en 
placed in a boiling water bath for four minutes. After cooling at room temperature 
for fifteen to twenty minutes, the contents of each tube were transferred to 3 ml 
silica cuvettes and read in a Beckman D. U. spectrophotometer at 390 ~µ, 425 
mf, and 460 mJ against the acid blank. The corrected reading does not appre ci ab ly 
change over a period of several hours. The intensity of the color is maximum at 
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425 mu. Many factors would influence the color density, such as, the length 
of time permitted for color developed by the individual pregnanediol, and the 
concentrations of sodium bisulfite and sulfuric acid . Th e refore, Alle n 's 
correction was followed to reduce the error (Allen, 1950). 
Calculation. The cor rected absorbanc e was calculated by the Br own 
modification of the Allen 1 s correction: 
2 absorbance 425 - (absorban ce 460 + absorbance 390) 
The excretion of 5 ~ -pregnane-30\, 20 o(-diol in urine for mg per 24-hour 
corrected absorbance unknown/ corrected absorbance known x 24-hour urin e 
volume/volume of urin e sample x mcg of standard used x 1/1000. 
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